PRO27 IMPLICATIONS OF INDICATION EXPANSION OF ORPHAN DESIGNATED DRUGS ON EXISTING PRICES ACROSS EUROPEAN MARKETS
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2357
https://www.valueinhealthjournal.com/article/S1098-3015(19)34735-7/fulltext
Title :
PRO27 IMPLICATIONS OF INDICATION EXPANSION OF ORPHAN DESIGNATED DRUGS ON EXISTING PRICES ACROSS EUROPEAN MARKETS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34735-7&doi=10.1016/j.jval.2019.09.2357
First page :
Section Title :
Open access? :
No
Section Order :
12056